Jillian B. Thomsen, SVP & Chief Accounting Officer at NEKTAR THERAPEUTICS (NKTR), sold 23,410 shares at $22.37 ($524K) on 2021-02-16, disclosed to the SEC on 2021-02-18.
Seasonal sale ($524k) by SVP & Chief Accounting Officer — this insider has traded NKTR in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.37 | 11,705 | $262K | 50.0% |
| 2 | $22.37 | 11,705 | $262K | 50.0% |
| Total | $22.37 avg | 23,410 | $524K | 100% |
| Filing → |
| NKTR | SELL | 2022-08-17 | $10K | — | Filing → |
| NKTR | SELL | 2022-05-17 | $23K | — | Filing → |
| NKTR | SELL | 2022-02-18 | $26K | — | Filing → |